Q/C Technologies, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Q/C Technologies, Inc. (QCLS) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $1.20 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-08-12
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $1.20K.
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $114.53K.
- 2022-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $8.79M.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $14.49M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2026-06-30 | $1.20K 10-Q · filed 2026-08-12 |
| 2022-09-30 | $114.53K 10-Q · filed 2022-11-10 |
| 2022-03-31 | $8.79M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $14.49M 10-K · filed 2023-03-31 |
| 2021-09-30 | $19.31M 10-Q/A · filed 2021-11-15 |
| 2021-06-30 | $15.54M 10-Q · filed 2021-08-16 |
| 2020-12-31 | $5.81M 10-K · filed 2022-03-31 |
| 2017-06-30 | $600.00 10-Q/A · filed 2018-07-13 |
| 2017-03-31 | $17.10K 10-Q · filed 2017-05-15 |
| 2016-12-31 | $20.10K 10-Q/A · filed 2018-07-13 |
| 2014-12-31 | $600.00 10-K · filed 2017-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |